POC Pharma, a Vietnam, and Hong Kong-based pharma industry-focused SaaS firm raised $10.3 million in Series A funding.
The round was led by Alven, along with co-investment from seed investors Picus Capital, FEBE Ventures, and FJ Labs who have doubled down their investments.
The funds will be used to accelerate the roll-out of its digital go-to-market solutions for the Pharmaceutical Industry in emerging countries, in Southeast Asia, South Asia, the Middle East, and Africa.
Company: POC Pharma Limited
Raised: $10.3M
Round: Series A
Funding Month: April 2022
Lead Investors: Alven
Additional Investors: Picus Capital, FEBE Ventures, and FJ Labs
Company Website: https://pharmapoc.com/
Software Category: Pharmacy Solutions
About the Company: Founded in 2019 by serial entrepreneur Thomas Miklavec, POC Pharma is a SaaS company helping stakeholders in the Retail Channel (drug manufacturers, distributors, wholesalers, pharmacies, clinics, etc.) digitally manage their interactions and collaborative workflows. POC Pharma’s software solutions offer omnichannel sales management, trade program systems, remote selling, and proprietary data. POC Pharma has already onboarded a dozen of global and regional pharmaceutical companies in Southeast Asia, with proven impact on performance: “Teams using POC Pharma solutions have increased their market share by 24%”. The company is now deploying its solutions in more geographies, with a hub opened in Dubai and new clients in South Asia and Africa.
Source: https://www.asiatechdaily.com/hong-kongs-poc-pharma-raises-10-3-million-in-series-a-funding/